| Name | Title | Contact Details |
|---|
Find quality addiction treatment in North Carolina, where you’ll experience the care, flexibility, and support you need to conquer substance use.
EcoNugenics® was founded in 1995 by Dr. Isaac Eliaz, M.D., M.S., L.Ac. - a pioneer and expert in the field of integrative medicine, and a highly regarded clinical practitioner, formulator, researcher and author. Dr. Eliaz leads our research activities in natural, integrative approaches to cellular, immune, metabolic, digestive, and cardiovascular health, as well as detoxification.
At Natura Life+Science, we are focused on creating the world`s most sophisticated platform for the production and distribution of cannabis products. We will commercialize the industry in the most responsible manner, and positively affect millions of lives.Established in Sacramento, California in 2018.
Healthcare industry veterans Joe Caruncho – whose success at the helm of Preferred Care Partners led to annual sales in excess of $750 million – and Orlando Lopez-Fernandez, Jr., MD, founded Genuine Health Group to usher in a new era of healthcare delivery focused on value instead of volume. Today, Genuine Health is building a model for managing care delivery that embodies traditional values, promises reliability, and embraces flexibility and technology. Through its accountable care organization, PremierMD ACO, the company aims to improve healthcare outcomes, achieve cost savings for the care of patients who receive traditional, fee-for-service Medicare benefits, and serve as a single point of contact to move doctors` Medicare members into value-based care. And, through its management service organization (MSO), the company aims to deliver financial upside for its participating physicians whose patients are enrolled in Medicare Advantage plans. For both traditional Medicare beneficiaries and those who choose managed care plans, Genuine Health and its providers are demonstrating the powerful effects of value-based care.
We are at the cutting-edge of medical development – and through our advanced clinical trials, novel medical device development and in-house cellular manufacturing and quality control expertise, we intend to lead the industry. We are uniquely positioned and expect to maintain our leadership position though active collaborations with physicians, researchers, hospitals and blood banks on a wide range of clinical, cell-based approaches to medical treatment.